Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A patch test is recommended before broader use
Administration and Dosage By slow intravenous injection
Naiki-Ito A, Asamoto M, Naiki T, Ogawa K, Takahashi S, Sato S, Shirai T
Documented adverse events in preclinical models include behavioral hyperactivity, serotonergic overstimulation, and autonomic instability when combining serotonergic peptides with SSRIs or MAOIs at doses previously considered safe independently
VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia
doi: 10.1016/s0928-4257(99)00119-9
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
